The patients, parents and advocates behind the #WeAreNotWaiting movement to access and utilize medical device and health data to improve life with diabetes.

Home / Big Data / Anna McCollister-Slipp
Anna McCollister-Slipp

Anna McCollister-Slipp

Anna McCollister-Slipp is co-founder of Galileo Analytics, a Visual Data Exploration and advanced data analytics company focused on democratizing access to and understanding of complex health data. In addition, she serves as Chief Advocate for Participatory Research at the Scripps Translational Science Institute, working with STSI researchers to develop new ways of involving patients, caregivers and physicians in the design of clinical research using digital and genomic health tools.

Anna’s passion for innovation in health data analytics, participatory research and digital health tools is rooted in her personal experiences living with type 1 diabetes. In her professional and personal activities, Anna seeks to build platforms for better understanding of and engagement with the needs of patients. She speaks frequently about the need for innovation in medical device data and technology, promoting data standards, device interoperability and user platforms aimed at empowering patients to better manage their health.

As a health IT entrepreneur and patient advocate, Anna has been appointed to and served on a number of government and private committees and boards aimed at promoting innovative ways to better understand, manage and treat complex chronic health conditions, such as diabetes. She was a member of the the ONC HIT Policy Committee’s FDASIA Workgroup, charged with advising the government on a regulatory pathway for HIT that would protect patients and promote innovation.

Anna’s work as an advocate and entrepreneur has been featured in an array of publications and online media, including Forbes, Huffington Post and US News & World Report. She was named by XX In Health as a “Woman to Watch” at Health Datapalooza 2013, and as co-founder of Galileo Analytics, was one of a select group of innovators invited to participate in “The Hive” at TEDMED 2013.

As part of her personal and professional advocacy, Anna has been appointed to and serves on a number of boards, working groups and committees. These include:

Current

  • Chief Advocate, Participatory Research, Scripps Translational Science Institute
  • Diabetes Collaborative Registry Stakeholder Panel, Diabetes Collaborative Registry Steering Committee of the American College of Cardiology’s National Cardiovascular Data Registry (NCDR)
  • CardioMetabolic Council, Food and Drug Administration’s Office of Constituent Relations,  Member
  • Qualcomm Tricorder X-Prize, Member of judging panel
  • Endocrine Standing Committee, National Quality Forum
  • Advisory Committee, General Hospital and Personal Use Devices Panel, Center for Devices and Radiological Health, Food and Drug Administration
  • Academy Health Consumer and Patient Roundtable
  • Steering Committee, 2015 Diabetes Mine Innovation Summit

Previous

  • Grant Application Review Committee, Patient Centered Outcomes Research Institute (PCORI), 2013 Funding Cycle, reviewed and scored grant applications for projects that would support the establishment of Clinical Data Research Networks to enable comparative effectiveness research.
  • Planning Committee, Center for Medical Technology Policy (CMTP), 2012 Comparative Effectiveness Research Summit (Focus on diabetes therapies)
  • ONC HIT Policy Committee FDASIA workgroup
  • Interim Steering Committee,  Medical Device Epidemiology Network (MDEpiNet), Center for Devices and Radiological Health, Food and Drug Administration
  • Steering Committee, Diabetes Mine Innovation Summit, 2013-2014

Leave a Reply

Scroll To Top
%d bloggers like this: